ELCOME, a global provider of maritime technology and satellite communication solutions, announced today that it has signed an authorized reseller agreement with Amazon Leo (formerly Project Kuiper) to offer satellite-based connectivity to the commercial maritime sector. Under this agreement, ELCOME will offer Amazon Leo to fleets operating across all major oceans, supporting merchant shipping, offshore […] The post ELCOME Expands Global Maritime Connectivity Leadership with Amazon Leo Agreement appeared first on Web-Release.

    Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.